In a filing, BeiGene Ltd ADR revealed its Shareholder (1) HHLR Advisors, Ltd. (1) acquired Company’s shares for reported $295.09 million on Dec 02 ’24. In the deal valued at $215.00 per share,1,372,500 shares were bought.
Then, Wang Xiaodong sold 40,468 shares, generating $7,693,071 in total proceeds. Upon selling the shares at $190.10, the Chair, Scientific Advisory Brd now owns 0 shares.
Before that, Wang Xiaodong sold 7,883 shares. BeiGene Ltd ADR shares valued at $1,497,499 were divested by the Chair, Scientific Advisory Brd at a price of $189.97 per share. As a result of the transaction, Wang Xiaodong now holds 0 shares, worth roughly $0.0.
JMP Securities initiated its BeiGene Ltd ADR [BGNE] rating to a Mkt outperform in a research note published on September 18, 2024; the price target was $288. Macquarie began covering BGNE with “an Outperform” recommendation on September 12, 2023. Jefferies started covering the stock on August 17, 2023. It rated BGNE as “a Buy”.
Price Performance Review of BGNE
On Monday, BeiGene Ltd ADR [NASDAQ:BGNE] saw its stock fall -4.30% to $205.75. Over the last five days, the stock has gained 8.00%. BeiGene Ltd ADR shares have risen nearly 14.08% since the year began. Nevertheless, the stocks have risen 10.06% over the past one year. While a 52-week high of $248.16 was reached on 10/04/24, a 52-week low of $126.97 was recorded on 04/19/24. SMA at 50 days reached $212.41, while 200 days put it at $176.35.
Levels Of Support And Resistance For BGNE Stock
The 24-hour chart illustrates a support level at 198.26, which if violated will result in even more drops to 190.76. On the upside, there is a resistance level at 214.99. A further resistance level may holdings at 224.22. The Relative Strength Index (RSI) on the 14-day chart is 52.91, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 13.56, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 34.06%. Stochastics %K at 81.53% indicates the stock is a selling.
How much short interest is there in BeiGene Ltd ADR?
A steep rise in short interest was recorded in BeiGene Ltd ADR stocks on 2024-11-15, dropping by -0.51 million shares to a total of 1.0 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 1.51 million shares. There was a decline of -51.12%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on July 17, 2023 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $275 price target.
